Comprehensive dosimetric comparison of halcyon 3.0 versus truebeam for breast cancer volumetric modulated arc therapy plans
Compared with TrueBeam, Halcyon achieved reduction in low-dose exposure while maintaining target coverage in breast cancer VMAT planning, thereby lowering radiation doses to OARs (e.g., heart and lung V5). This benefit is likely attributed to Halcyon's unique staggered dual-layer MLC design.
Authors
- Mengyuan Wang
- Ran Tang (ORCID: https://orcid.org/0000-0003-3664-2497)
- Y. Li
- Yu Wu (ORCID: https://orcid.org/0000-0001-8708-9711)
- Xingru Sun
- Anyan Gu
- Zhenyu Pan (ORCID: https://orcid.org/0000-0003-1742-0629)
- Guozi Yang (ORCID: https://orcid.org/0000-0003-4139-0546)
Institutions
- Central People's Hospital of Zhanjiang (CN)
- Guangzhou Medical University (CN)
- Huizhou University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-08-20
- DOI
- https://doi.org/10.3389/fonc.2025.1630702
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Guangzhou Medical University
- Basic and Applied Basic Research Foundation of Guangdong Province